FDA Approves Cymbalta(R) for the Management of Fibromyalgia … fourth disorder that the FDA has approved for Cymbalta … diabetic peripheral neuropathic pain (DPNP) and the treatment of major depressive disorder and generalized anxiety disorder …[Lilly Press Release]

Editor's Note: Cymbalta retails for $4.30 per day, is not a controlled substance, and is given once per day but it has a suicide warning; Lyrica costs $4.75 per day is given twice daily, is a controlled substance and has no suicide warning.  Our opinion is that the once-per-day dosing and lower cost for Cymbalta willlead to rapid traction and steal share from Lyrica.